Pharmacological Treatment of Mental Disorders in Primary Health Care PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Pharmacological Treatment of Mental Disorders in Primary Health Care PDF full book. Access full book title Pharmacological Treatment of Mental Disorders in Primary Health Care by World Health Organization. Download full books in PDF and EPUB format.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Get Book Here
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Get Book Here
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Author: Florian Holsboer
Publisher: Springer Science & Business Media
ISBN: 9783540225683
Category : Medical
Languages : en
Pages : 588
Get Book Here
Book Description
The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
Author: Mike Briley
Publisher: Springer Science & Business Media
ISBN: 9783764360320
Category : Medical
Languages : en
Pages : 200
Get Book Here
Book Description
For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.
Author: Mike Briley
Publisher: Birkhäuser
ISBN: 3034884702
Category : Medical
Languages : en
Pages : 183
Get Book Here
Book Description
For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.
Author: Giorgio Racagni
Publisher: Seattle ; Toronto : Hogrefe & Huber
ISBN: 9780889370883
Category : Anxiety disorders
Languages : en
Pages : 0
Get Book Here
Book Description
This brief and readable review of anti-anxiety drugs is an ideal primer for a wide variety of health care providers, such as family physicians, mental health professionals, nurse practitioners, and social workers, who do not currently function as psychopharmacology specialists. The authors provide a quick introduction to this important and very widely used class of medications, and clearly explain their advantages, as well as their pharmacological profiles, and peripheral side effects.
Author: David Herzberg
Publisher: JHU Press
ISBN: 1421400995
Category : Medical
Languages : en
Pages : 292
Get Book Here
Book Description
Valium. Paxil. Prozac. Prescribed by the millions each year, these medications have been hailed as wonder drugs and vilified as numbing and addictive crutches. Where did this “blockbuster drug” phenomenon come from? What factors led to the mass acceptance of tranquilizers and antidepressants? And how has their widespread use affected American culture? David Herzberg addresses these questions by tracing the rise of psychiatric medicines, from Miltown in the 1950s to Valium in the 1970s to Prozac in the 1990s. The result is more than a story of doctors and patients. From bare-knuckled marketing campaigns to political activism by feminists and antidrug warriors, the fate of psychopharmacology has been intimately wrapped up in the broader currents of modern American history. Beginning with the emergence of a medical marketplace for psychoactive drugs in the postwar consumer culture, Herzberg traces how “happy pills” became embroiled in Cold War gender battles and the explosive politics of the “war against drugs”—and how feminists brought the two issues together in a dramatic campaign against Valium addiction in the 1970s. A final look at antidepressants shows that even the Prozac phenomenon owed as much to commerce and culture as to scientific wizardry. With a barrage of “ask your doctor about” advertisements competing for attention with shocking news of drug company malfeasance, Happy Pills is an invaluable look at how the commercialization of medicine has transformed American culture since the end of World War II.
Author: John Vanin
Publisher: Springer Science & Business Media
ISBN: 1597452637
Category : Medical
Languages : en
Pages : 271
Get Book Here
Book Description
This pocket guide is designed to help the primary care practitioner recognize, diagnose, and manage anxiety disorders in a busy clinical practice. It presents an easy-to-follow, step-by-step approach, and offers practical points based on both real patient-care experience and review of current medical literature. The guide includes helpful chapters on psychopharmacology, psychopharmacotherapy, and psychologic treatment for the anxiety disorders.
Author: S.E. File
Publisher: Elsevier
ISBN: 1483287521
Category : Medical
Languages : en
Pages : 285
Get Book Here
Book Description
Contributed volume reviewing the clinical and animal literature related to the pharmacology of anxiety and depression. The role of the hypothalmic-pituitary-adrenal axis in anxiety and depression is reviewed as well as the response of central catecholamines to chronic stress.
Author: Hyman J. Zimmerman
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781719520
Category : Medical
Languages : en
Pages : 848
Get Book Here
Book Description
Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury.
Author: Jacqueline Burchum
Publisher: Elsevier Health Sciences
ISBN: 0323370004
Category : Medical
Languages : en
Pages : 321
Get Book Here
Book Description
Complex pharmacologic information is simple to learn with this complete study resource! Designed to accompany Lehne’s Pharmacology for Nursing Care, 9th Edition, this robust workbook features critical thinking study questions, case studies, and patient teaching scenarios that help you connect pharmacology concepts with their impact on patient care. Plus, an emphasis on priority nursing care with NCLEX examination-style review questions prepares you for success on the exam. NCLEX Examination-style questions are included in each chapter. NEW! NCLEX-style alternate format questions including prioritization questions, bolster your readiness for the NCLEX Exam while supporting review of core pharmacology content NEW! Increased emphasis on patient safety features questions on safe patient care that challenge you to select appropriate actions to prevent or remediate medication errors. NEW! Detailed rationales for all prioritization questions are included in the answer key and encompass explanations for both correct and incorrect responses.
